Ole-Christian Lingjærde
Universitetet i Oslo
H-index: 48
Europe-Norway
Top articles of Ole-Christian Lingjærde
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract PS03-01: Single cell analysis of paired lymph nodes and primary tumors in breast cancer patients | Cancer Research | Marit Fjørtoft Inga Rye Kanutte Huse June Myklebust Hege Russnes | 2024/5/2 |
260 ViRP signature predicts response to treatment with chemotherapy and bevacizumab in ovarian cancer–a translational study of the ICON-7 trial’ | Kristina Lindemann Mads H Haugen Jacobus Pfisterer Gunhild M Mælandsmo Stefan Kommoss | 2024/3/1 | |
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial | Journal for immunotherapy of cancer | Nikolai Kragøe Andresen Andreas Hagen Røssevold Claire Quaghebeur Bjørnar Gilje Beate Boge | 2024 |
Pre-treatment protein landscape in HER2-negative breast cancer treated with carboplatin in a neoadjuvant chemotherapy setting | Cancer Research | Maria Aanesland Dahle Eivind Valen Egeland Lina Prasmickaite Ole Christian Lingjærde Hege Russnes | 2023/4/4 |
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets | EBioMedicine | Maren Høland Kaja CG Berg Ina A Eilertsen Bodil Bjerkehagen Matthias Kolberg | 2023/11/1 |
Spatial protein profiling by cyclic immunofluorescence to interpret and improve bulk tumor-based predictor of response to chemotherapy with bevacizumab in neoadjuvant breast … | Cancer Research | Mads Haugland Haugen David Kilburn Hongli Ma Cameron Watson Allison Creason | 2023/4/4 |
Biomarkers predicting clinical response of a vegf-a inhibitory drug in cancer patients, method for their selection and use | 2023/10/26 | ||
Author Correction: Pan-cancer analysis of whole genomes | Nature | 2023/2/16 | |
Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy | Leukemia & lymphoma | E Leich Marianne Brodtkorb T Schmidt Michael Altenbuchinger Ole Christian Lingjærde | 2023/10/15 |
Author Correction: The evolutionary history of 2,658 cancers (Nature,(2020), 578, 7793,(122-128), 10.1038/s41586-019-1907-7) | Nature | Moritz Gerstung Clemency Jolly Ignaty Leshchiner Stefan C Dentro Santiago Gonzalez | 2023/2/16 |
The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy | Haematologica | Kathrine T Isaksen Renate Galleberg Maria Adele Mastroianni Marit Rinde Leiv Sindre Rusten | 2023/9/9 |
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing | Nature genetics | Isidro Cortés-Ciriano Jake June-Koo Lee Ruibin Xi Dhawal Jain Youngsook L Jung | 2023/6 |
Abstract P1-08-09: high mid-treatment RNA disruption in patients with HER2-negative breast cancer predicts survival benefit after neoadjuvant chemotherapy | Cancer Research | Laura B Pritzker Mads Haugland Haugen Hedda von der Lippe Gythfeldt Twinkle Masilamani Gabriel Theriault | 2022/2/15 |
Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma | Blood | Baoyan Bai Jillian F Wise Daniel Vodák Sigve Nakken Ankush Sharma | 2022/11/15 |
Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression | Molecular Oncology | Inga Hansine Rye Kanutte Huse Sarah E Josefsson Wanja Kildal Håvard E Danielsen | 2022/1 |
215MO ICON–a randomized phase IIb study evaluating chemotherapy combined with ipilimumab and nivolumab in metastatic hormone receptor-positive breast cancer | Annals of Oncology | JA Kyte NK Andresen C Quaghebeur B Gilje B Boge | 2022/9/1 |
Proteome analysis of pancreatic tumors implicates extracellular matrix in patient outcome | Cancer Research Communications | Laxmi Silwal-Pandit Stina M Stålberg Henrik J Johansson Georgios Mermelekas Inger Marie B Lothe | 2022/6/14 |
NRF2 drives an oxidative stress response predictive of breast cancer | Free Radical Biology and Medicine | Camilla Wolowczyk Ulrike Neckmann Miriam Ragle Aure Martina Hall Bjarne Johannessen | 2022/5/1 |
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma | Frontiers in oncology | Anand Khadse Vilde D Haakensen Laxmi Silwal-Pandit Julian Hamfjord Patrick Micke | 2022/4/29 |
Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers | Nucleic Acids Research | Jaime A Castro-Mondragon Miriam Ragle Aure Ole Christian Lingjærde Anita Langerød John WM Martens | 2022/11/28 |
